The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for KW Pankiewicz


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure.EBI
University of Minnesota
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.EBI
Pharmasset
Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.EBI
Codon Pharmaceuticals
Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.EBI
Codon Pharmaceuticals
CNAD: a potent and specific inhibitor of alcohol dehydrogenase.EBI
University of Rochester Medical Center
Synthesis of isosteric analogues of nicotinamide adenine dinucleotide containing C-nucleotide of nicotinamide or picolinamide.EBI
Cornell University
Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.EBI
University of Minnesota
Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis.EBI
University of Minnesota
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues.EBI
University of Minnesota
Mycophenolic acid analogs with a modified metabolic profile.EBI
University of Minnesota
Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.EBI
University of Minnesota
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.EBI
University of Minnesota
Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.EBI
University of Minnesota
Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor.EBI
University of Minnesota
Probing binding requirements of NAD kinase with modified substrate (NAD) analogues.EBI
University of Minnesota
Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.EBI
University of Minnesota
NAD-based inhibitors with anticancer potential.EBI
University of Minnesota
Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-beta-carbolines.BDB
Cnrs